Donald Hooker
Stock Analyst at Keybanc
(2.50)
# 2,118
Out of 5,182 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $6.00 | +1,566.67% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $166.79 | +133.83% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $195.05 | -12.84% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $158.98 | +82.41% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $9.42 | +674.95% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $3.41 | +955.72% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $6.25 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $158.49 | +122.73% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $81.18 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $65.38 | +28.48% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.62 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $259.57 | -34.51% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $102.49 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.87 | +5,207.49% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $409.65 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $6.00
Upside: +1,566.67%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $166.79
Upside: +133.83%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $195.05
Upside: -12.84%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $158.98
Upside: +82.41%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $9.42
Upside: +674.95%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $3.41
Upside: +955.72%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $6.25
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $158.49
Upside: +122.73%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $81.18
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $65.38
Upside: +28.48%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.62
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $259.57
Upside: -34.51%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $102.49
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.87
Upside: +5,207.49%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $409.65
Upside: -